Pharma Journalist -

The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut…
Read More...

Did you know... the global ophthalmic drug market is projected to reach £30 billion by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Ophthalmic News: ELASMOGEN: Dr Caroline…
Read More...

Shire plc announced that the United States Food and Drug Administration (FDA) has approved the company's first submission for its new plasma manufacturing facility near Covington,…
Read More...

Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of € 3…
Read More...

Roche announced that it has signed a collaboration agreement and investment in Care Innovations, a leader in telehealth solutions that remotely connects people living with chronic…
Read More...

This year, MEDICAL FAIR ASIA will stage its largest edition to date, with over 1,000 exhibitors including 24 country groups, over 10,000 medical and healthcare products, as well as the…
Read More...

Mustang Bio announced that it has opened a CAR T cell therapy manufacturing facility at UMass Medicine Science Park in Worcester, Mass. The 27,000 sq. ft. facility will support the…
Read More...

WuXi Biologics and Harbour BioMed announced an initial strategic collaboration for the development and manufacturing of Harbour's leading HCAb antibody. The collaboration with WuXi…
Read More...

Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during…
Read More...

Samsung BioLogics announced that it has licensed by the Health Canada for manufacturing a monoclonal antibody Drug Substance at its first plant. This is a great milestone for…
Read More...